Xiuying Xiao

160 Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Human Pancreatic Cancer Organoids.

Human Pancreatic Cancer Organoids.

Journal: Cell proliferation

Published: March 02, 2026

Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib.

Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib.

Journal: International journal of biological sciences

Published: October 27, 2025

Histone 3 lysine 36 trimethylation by SETD2 shapes an epigenetic landscape in intestinal stem cells to orchestrate lipid metabolism and attenuate cell senescence.

Histone 3 lysine 36 trimethylation by SETD2 shapes an epigenetic landscape in intestinal stem cells to orchestrate lipid metabolism and attenuate cell senescence.

Journal: Cell death & disease

Published: June 14, 2025

Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier.

Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 06, 2025

Automated interpretation of PD-L1 CPS based on multi-AI models integration strategy in gastric cancer.

Automated interpretation of PD-L1 CPS based on multi-AI models integration strategy in gastric cancer.

Journal: Frontiers in immunology

Published: April 18, 2025

Comprehensive exome profiling identifies ARHGEF12 mutation as a driver in gastric cancer with ovarian metastasis.

Comprehensive exome profiling identifies ARHGEF12 mutation as a driver in gastric cancer with ovarian metastasis.

Journal: Theranostics

Published: March 07, 2025

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial.

CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial.

Journal: Nature medicine

Published: December 10, 2024

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.

Epithelial NSD2 maintains FMO-mediated taurine biosynthesis to prevent intestinal barrier disruption.

Journal: Clinical and translational medicine

Published: August 09, 2024

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Journal: Cell reports

Published: August 01, 2024

Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer.

Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: July 11, 2024

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Journal: Cell metabolism

Published: July 02, 2024

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Journal: Cancer discovery

Published: March 22, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026